Agilon Health, Inc. (AGL) Stock Overview
Explore Agilon Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Agilon Health, Inc. (AGL)
Key Financials
Key Financials
Market Cap
1.9B
P/E Ratio
-17.36
EPS (TTM)
$-15.41
ROE
-0.52%
AGL Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Agilon Health, Inc. (NYSE: AGL) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Agilon Health, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AGL on the NYSE shows an RSI of 76.63, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $70.81 for the NYSE listing.
Key metrics behind Agilon Health, Inc.'s NYSE-traded stock include a P/E ratio of -17.36 and a market capitalization of 1.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AGL on the NYSE.